Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Finding the right semaglutide dose is crucial for safe, effective weight loss—but the 'therapeutic' amount differs from person to person. A therapeutic dose is simply the amount that produces meaningful metabolic benefit without excessive side effects. PlexusDx specializes in precision dosing protocols using genetic insights to help you reach your target faster.

What Makes a Semaglutide Dose Therapeutic

A therapeutic dose of semaglutide is one that activates your GLP-1 and GIPR receptors enough to reduce hunger, slow stomach emptying, and support metabolic changes—without causing intolerable nausea or other adverse effects. Clinical trials show that doses between 0.5 mg and 2.4 mg weekly produce meaningful weight loss, but the 'sweet spot' depends on your genetics, starting weight, and metabolic sensitivity. For most people, therapeutic benefit begins around 1.0 to 1.2 mg weekly, though some respond at lower or higher amounts.

The goal is not maximum dose—it's optimal dose. Research in Obesity and the New England Journal of Medicine demonstrates that gradual titration (slow increase) over 16–20 weeks reduces side effects while allowing your body to adapt. This is why many patients start at 0.25 mg and increase by 0.25 mg every 4 weeks. PlexusDx follows evidence-based protocols to help you climb to your therapeutic level safely, with your monthly cost remaining flat regardless of dose progression.

Why Individual Genetics Shape Your Optimal Semaglutide Dose

Not everyone's body responds to the same semaglutide amount equally. Genetic variations in the GLP1R gene (the receptor semaglutide activates) and the GIPR gene (which influences glucose-dependent insulin secretion) influence both efficacy and side-effect sensitivity. The Precision Peptide Genetic Test from PlexusDx maps 14 metabolic pathways and 150+ genetic insights, including key variants like GLP1R rs6923761 and GIPR rs1800437, to reveal how your peptide system is wired.

Patients carrying certain FTO or MC4R variants often require different titration schedules to reach their therapeutic dose. Rather than guessing whether you need 0.5 mg or 2.4 mg weekly, knowing your genetic profile lets PlexusDx recommend a personalized dosing roadmap from day one. This reduces trial-and-error side effects and accelerates your path to weight loss success.

Compounded Semaglutide vs. Brand-Name Wegovy: Dosing Flexibility

Brand-name Wegovy comes in pre-filled pens at fixed doses (0.25, 0.5, 1.0, and 2.4 mg), which means your dose adjustments are limited to those exact amounts. Compounded semaglutide from licensed 503A pharmacies, like those PlexusDx partners with, offers flexible dosing in 0.1 mg increments. This granularity allows your prescriber to fine-tune your dose more precisely—for example, going from 0.8 mg to 0.9 mg instead of jumping to 1.0 mg.

The flexibility matters especially during titration and if you're navigating side effects. With compounded semaglutide starting at $149/month from PlexusDx, you gain both precision and affordability. Your dose may increase as you progress toward your therapeutic target, but your price remains fixed—no cost escalation as you adjust.

Signs You've Reached Your Therapeutic Semaglutide Dose

A therapeutic semaglutide dose typically produces noticeable appetite suppression (feeling full faster and longer), modest nausea during the first few days after injection that decreases over time, and steady weekly weight loss of 0.5–1.5 pounds on average. You should feel in control of hunger rather than struggling against it, and your blood sugar patterns may stabilize. Most patients recognize therapeutic benefit within 4–8 weeks of reaching a stable dose.

If you're experiencing severe nausea, vomiting, or no appetite suppression at your current dose, your therapeutic level may need adjustment. This is where PlexusDx's prescriber guidance is valuable—they monitor your response and modify your protocol based on your individual feedback, genetic test results, and metabolic markers. The goal is reaching the dose that maximizes benefit while keeping side effects manageable for you specifically.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard starting dose of semaglutide for weight loss?

Standard practice is to begin at 0.25 mg once weekly, then increase by 0.25 mg every 4 weeks until reaching a therapeutic dose—usually between 1.0 and 2.4 mg weekly. PlexusDx compounded semaglutide (starting at $149/month) allows micro-adjustments within this range based on your response and genetic profile.

How long does it take to reach therapeutic semaglutide dosing?

Most people reach a therapeutic dose within 16–20 weeks of gradual titration. Clinical evidence supports this slower approach to minimize side effects and improve long-term adherence. Your exact timeline depends on how your body tolerates each increase and your genetic predisposition to GLP-1 receptor sensitivity.

Does my semaglutide price increase when my dose goes up?

No. PlexusDx pricing is flat—compounded semaglutide injection starts at $149/month and stays that price regardless of your dose level. Your dose may need to go up as you progress, but your cost won't.

What happens if therapeutic semaglutide dosing causes too many side effects?

If nausea or other side effects are intolerable, a dose reduction by 0.1–0.25 mg can often improve tolerability while maintaining metabolic benefit. Some patients also benefit from anti-nausea strategies (eating smaller meals, staying hydrated) or adjusting injection timing. PlexusDx prescribers work with you to find the highest therapeutic dose you can tolerate.

Can the Precision Peptide Genetic Test predict my ideal semaglutide dose?

The Precision Peptide Genetic Test ($99 add-on after your first month) identifies genetic variants affecting GLP1R, GIPR, FTO, and MC4R pathways that influence your peptide sensitivity and optimal dosing range. While it doesn't predict an exact dose, it guides your prescriber toward a personalized titration plan that typically reaches therapeutic levels faster with fewer side effects.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves